DAFTAR PUSTAKA

1. Silvi S, Athuf T, Rusawardiana, Suryadi R.M.T. Nilai Diagnostik Leprosy Rapid

Test untuk Menegakkan Diagnosis Morbus Hansen. Departemen Ilmu Kesehatan
Kulit dan Kelamin, Fakultas Kedokteran. Palembang: Unsri/RSMH 2015.
2. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI). Panduan
Praktik Klinis bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta:
PERDOSKI 2017.
3. Ikatan Dokter Indonesia. Panduan Praktik Klinis bagi Dokter di Fasilitas Pelayanan
Kesehatan Primer. Jakarta: Ikatan Dokter Indonesia 2014.
4. Lee DJ, Rea TH, Modlin RL. Leprosy. In: Wolff K, Goldsmith LA, Kat SI,
Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General
Medicine. Vol 2. 8th ed. New York: McGraw-Hill Companies 2012; 2253-63.
5. Lyon S, Lyon AC, da Silva RC, Grossi MA, Lyon SH, et al. A comparison of ML
flow serology and slit skin smears to assess the bacterial load in newly diagnosed
leprosy patients in Brazil. Lepr Rev 2008; 79: 162-70.
6. Parkash O, Kumar A, Pandey R, Nigam A, Girdhar BK. Performance of a lateral
flow test for the detection of leprosy patients in India. J Med Microbiol 2008;
57:130-2.
7. Bu¨hrer-Se´kula S, Smits HL, Gussenhoven GC et al. Simple and fast lateral Flow
Test for classification of leprosy patients and identification of contacts with high
risk of developing leprosy. J Clin Microbiol 2003; 41: 1991 – 95.
8. Bryceson A, Pfaltzgraff RE. Immunology. In: Bryceson A, Pfaltzgraff RE, editors.
Leprosy. 3rd ed. London: Churchill Livingstone 1990; 93-113.
9. Kar HK, Kumar B. IAL Textbook of Leprosy. New Delhi: Jaypee Brothers Medical
Publishers LTD 2010.
10. Deps PD, Guedes BV, Bucker FJ, Andreatta MK, Marcari RS, Rodrigues LC. Delay
in diagnosis of leprosy in the Metropolitan Region of Vitoria, Brazil. Lepr Rev
2006; 77: 41-7.
11. Van Veen NH, Meima A, Richardus JH. The relationship between detection delay
and impairment in leprosy control: a comparison of patient cohorts from Bangladesh
and Ethiopia. Lepr Rev 2006; 77: 356-65.

29
12. Lyon S, da Silva RC, Lyon AC, Grossi MA, Lyon SH, Azevedo M, et al.
Association of the ML flow serological test with slit skin smear. Rev Soc Bras Med
Trop 2008; 41: 23-6
13. Duthie MS, Balagon MF, Maghanoy A, Orcullo FM, Cang M, Dias RF, et al. Rapid
quantitative serological test for detection of infection with Mycobacterium leprae,
the causative agent of leprosy. J Clin Microbiol 2014; 52: 613-9.
14. Widodo AA, Menaldi SL. Characteristics of leprosy patients in Jakarta. J Indon
Med Assoc 2012; 62:423-7.
15. Sekula SB, Illarramendi X, Teles RB, Penna MLF, Nery JAC, Sales AM, et al. The
additional benefit of the ML flow test to classify leprosy patients. Acta Trop 2009;
111: 172-6
16. World Health Organization. A guide to eliminating leprosy as a public health
problem. Geneva 1997.
17. Ridley DS, Jopling WH. Classification of leprosy according to immunity: five group
system. Int J Lepr 1966; 34: 255 – 273.
18. Norman G, Joseph G, Richard J. Validity of the WHO operational classification and
value of other clinical signs in the classification of leprosy. Int J Lepr 2004; 72: 278
– 83.
19. Oskam L, Slim E, Bu¨hrer-Se´kula S. Serology: recent developments, strengths,
limitations and prospects: a state of the art overview. Lepr Rev 2003; 74: 196 – 205.
20. Van Beers, S. M., M. Hatta, and P. R. Klatser. Patient contact is the major
determinant in incident leprosy: implications for future control. Int. J. Lepr. Other
Mycobact. Dis 1999; 67:119–28.
21. Roche, P. W., W. J. Britton, S. S. Failbus, D. Williams, H. M. Pradhan, and W. J.
Theuvenet. Operational value of serological measurements in multibacillary leprosy
patients: clinical and bacteriological correlates of antibody responses. Int. J. Lepr.
Other Mycobact. Dis 1990; 58:480–90.
22. Klatser, P. R., S. N. Cho, and P. J. Brennan. The contribution of serological tests to
leprosy control. Int. J. Lepr. Other Mycobact. Dis 1996; 64: S63–6.
23. Gigg, J., R. Gigg, S. Payne, and R. Conant. The allyl group for protection in
carbohydrate chemistry. 17. Synthesis of propyl O-(3,6-di-O-methyl-beta-D-
glucopyranosyl)-(1—-4)-O-(2,3-di-O-methyl-alpha-L-rham-nopyranosyl)-(1—-2)-
3-O-methyl-a. Chem. Phys. Lipids 1985; 38:299–307.

30
24. Croft, R. P., W. C. Smith, P. Nicholls, and J. H. Richardus. Sensitivity and
specificity of methods of classification of leprosy without use of skin-smear
examination. Int. J. Lepr. Other Mycobact. Dis 1998; 66:445–50.
25. Cho, S. N., D. L. Yanagihara, S. W. Hunter, R. H. Gelber, and P. J. Brennan.
Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use
in serodiagnosis of leprosy. Infect. Immun 1983; 41:1077–83.
26. Cho, S. N., T. Fujiwara, S. W. Hunter, T. H. Rea, R. H. Gelber, and P. J. Brennan.
Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl
epitope for the serodiagnosis of leprosy. J. Infect. Dis 1984; 150:311–22.
27. Buhrer-Sekula, S., E. N. Sarno, L. Oskam, S. Koop, I. Wichers, J. A. Nery, L. M.
Vieira, H. J. de Matos, W. R. Faber, and P. R. Klatser. Use of ML dipstick as a tool
to classify leprosy patients. Int. J. Lepr. Other Myco-bact. Dis 2000; 68:456–63.

31